GLP-1 / GIPMost PopularHover to zoomVials — GLP-1
Tirzepatide
GIP/GLP-1 dual-agonist — the gold standard in modern recomposition.
View lab testing & COAs →- Regular
- …
- Elite Member−10%
- —
Research Use Only
This product is intended exclusively for laboratory and research purposes. Not for human or animal consumption.
Tirzepatide is a synthetic dual GIP/GLP-1 receptor agonist supplied in lyophilized form. Manufactured to research-grade specification for laboratory use only.
Research applications include incretin receptor signaling, glucose homeostasis, appetite-pathway modeling, and metabolic composition studies.
Research Use Only. This product is intended exclusively for laboratory research and is not approved for human or veterinary use.
Appetite, recalibrated.
Dual Receptor Action
Engages GLP-1 and GIP for stronger satiety than single-agonist options.
Glucose Stability
Smooths post-meal glucose curves across the week.
Weekly Cadence
One subcutaneous dose per week — built for executive routines.
Ingredients, disclosed.
Every compound. Every dose. Nothing proprietary, nothing hidden.
Composition, documented.
- Molecular Formula
- C225H348N48O68
- Molar Mass
- 4813.5 g/mol
- Amino Acid Sequence
- Y-Aib-EGTFTSDYSI-Aib-LDKIAQKAFVQWLIAGGPSSGAPPPS (K20 conjugated to γGlu-γGlu-C20 diacid)
- Synonyms
- LY3298176, GIP/GLP-1 dual receptor agonist
- Solubility
- Water-soluble
- Organoleptic Profile
- White to off-white powder
- Composition
- Lyophilized powder
